- Older dog cries at shelter when owners leave with younger pup
- Dog saves its owner from deadly snake sneaking up on him
- These are the most annoying Facebook posts according to each state
- CDC: Young women should avoid alcohol unless they're using birth control
- Day care director caught on video throwing child, police said
Former Turing Pharmaceuticals CEO Martin Shkreli declined to speak at a congressional hearing, but he wasn’t shy about sharing his feelings about the experience on Twitter.
Shkreli appeared Thursday morning before a House Oversight and Government Reform hearing on ''Developments in the Prescription Drug Market Oversight,” but declined to testify, invoking his Fifth Amendment right against self-incrimination.
At one point during the hearing, Shkreli tells Rep. Trey Gowdy, R-S.C., “I intend to follow the advice of my counsel, not yours.”
He revealed on Twitter what he really thought about the government officials before whom he appeared.
When a reporter asked about his voting record, Shkrelil responded succinctly.
Shkreli sparked outrage last September after raising the price of Daraprim, a medication used to treat infections in those with HIV and cancer, by 5,000 percent. The medication, which cost $13.50 per pill before Shrkreli’s company acquired it, now costs $750 per pill. Some patients take the drug daily for years.
His business practices were investigated and Shkreli was arrested in December by the FBI for his alleged part in a securities fraud scheme. The same month, Shkreli’s drug company, KaloBio, filed for bankruptcy.
Shkreli has maintained his innocence.
Read more:
Hedge fund manager raises price of HIV drug 5,000 percent
Pharma Bro Martin Shkreli's drug company files for bankruptcy
'Pharma Bro' Martin Shkreli arrested in FBI securities fraud
About the Author
